Obesity indicators and cardiometabolic status in 4-y-old children

Camila Corvalán1, Ricardo Uauy, Juliana Kain

  • 1Nutrition and Health Sciences Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, USA. ccorvalan@meduchile.cl

Insights

Childhood obesity is common, but indicators like BMI and waist circumference poorly predict cardiometabolic risk factors in 4-year-olds. Further research is needed to understand these relationships in early childhood.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Public Health Nutrition

Background:

  • Obesity is linked to cardiovascular disease risk factors in adults and adolescents.
  • Evidence regarding these associations in preschool-aged children is limited.

Purpose of the Study:

  • To investigate the relationship between obesity indicators and cardiometabolic risk factors in 324 Chilean children aged 4 years.
  • To assess the prevalence of obesity, central obesity, and cardiometabolic risk in this population.

Main Methods:

  • Anthropometric measurements were taken to calculate general obesity indicators (e.g., BMI, body fat percentage) and central obesity indicators (e.g., waist circumference).
  • Blood samples were analyzed for C-reactive protein, interleukin-6, insulin resistance (HOMA-IR), and lipid profiles (triglycerides, total, LDL, HDL cholesterol).
  • Correlation and multiple linear regression analyses were employed to examine associations.

Main Results:

  • High prevalence of obesity (13%), central obesity (11%), and lipid disorders (>20%) was observed.
  • 70% of children had at least one cardiometabolic risk factor.
  • Obesity indicators were moderately to strongly correlated with central obesity indicators.
  • Obesity was weakly associated with C-reactive protein and insulin resistance in girls, but unrelated to interleukin-6 and lipid levels.
  • Obesity indicators explained a maximum of 8% of the variability in cardiometabolic risk factors.

Conclusions:

  • Obesity and central obesity are prevalent in 4-year-old Chilean children, with most exhibiting at least one cardiometabolic risk factor, especially lipid disorders.
  • Obesity and central obesity indicators are highly intercorrelated but weakly associated with cardiometabolic status at this age.
  • Body mass index and waist circumference are poor predictors of cardiometabolic status in preschool children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...